4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-20-054653
Options or other derivatives
- Chief Business Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rona Jeffrey A Chief Business Officer | 2020-10-11 | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | D | ||
Loading xslF345X03/doc4.xml…